Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK0529 in Adult RSV Infection
CTR20181808Phase 2Terminated
- Sponsor
- Aicobio
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ziresovir in respiratory syncytial virus disease (RSV), sponsored by Aicobio. Started Dec 2018; status: terminated.
02
Drugs
ziresovir
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on CTR20181808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181808.